Smith David V 4
4 · IO Biotech, Inc. · Filed Mar 3, 2022
Insider Transaction Report
Form 4
IO Biotech, Inc.IOBT
Smith David V
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-03-01+28,019→ 28,019 totalExercise: $6.89Exp: 2032-03-01→ Common Stock (28,019 underlying)
Footnotes (1)
- [F1]These options vest monthly over three years from the vesting commencement date of March 1, 2022, subject to the reporting person's continued service through the applicable vesting date, and subject to 100% acceleration upon a change of control.